Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study
BACKGROUND: Trimetazidine (TMZ) modulates cardiac metabolism, but its use in heart failure remains controversial. The aim of the study was to evaluate the effects of TMZ on exercise capacity, left ventricular ejection fraction (LVEF), mortality, and quality of life in stable patients with heart fail...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Via Medica
2022-07-01
|
| Seria: | Cardiology Journal |
| Hasła przedmiotowe: | |
| Dostęp online: | https://journals.viamedica.pl/cardiology_journal/article/view/65841 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|